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 INTRODUCTION 
 Cysticercosis (CC) is a zoonosis caused by the larval stage 
of  Taenia solium , which locates in the muscles and/or central 
nervous system causing, in the latter case, neurocysticercosis 
(NCC). 1 The presence of the parasite in the muscles is often 
asymptomatic. In contrast, NCC may cause important neuro-
logical disorders, such as epilepsy, and even death. Diagnosis 
of CC requires the use of imaging and serological techniques. 2 
Based on these tools, hospital-based studies have been con-
ducted to determine the NCC prevalence and diagnostic 
performances of serological tests among epileptic patients. 
Additionally, epidemiological studies are useful to understand 
the transmission dynamics of the parasite. 3, 4 However, it is 
known that the sensitivity and specificity of a test may vary 
when applied on symptomatic versus asymptomatic individu-
als. The use of estimates of the sensitivity and specificity of a 
diagnostic tool based on a selected population of symptom-
atic patients would, therefore, not be completely appropriate 
in the framework of an epidemiological study. 5 Estimations of 
the performances of a test for its use among an entire exposed 
population are then required. However, such studies on CC 
face two main constraints: (1) for ethical and practical rea-
sons, imaging techniques such as magnetic resonance imaging 
(MRI) and computed tomography (CT) scan are not appli-
cable in the field, and (2) epidemiological studies should not 
only focus on NCC but all CC cases to understand the trans-
mission dynamics of the parasite, and gold-standard meth-
ods (diagnostic methods having a sensitivity and specificity of 
100%) are lacking for this purpose. Under these conditions, 
estimating the prevalence of CC and the sensitivity and spec-
ificity of a test is only possible using a Bayesian approach. 
Bayesian statistical modeling is based on the integration of 
the results of multiple diagnostic tests together with prior 
knowledge on the characteristics (sensitivity and/or specific-
ity) of these tests. 6 The aim of the present study was to esti-
mate the performances of three serological diagnostic tests 
and the prevalence of CC using a Bayesian approach in a 
south Ecuadorian community where  T. solium is endemic. Two 
different definitions of a case have been considered to make 
a distinction between prevalence of infection (proportion of 
individuals currently infected with living cysticerci) and prev-
alence of prior exposure to  T. solium (proportion of individ-
uals who have been in contact with the parasite during the 
precedent year, with or without development of cysticerci and 
with or without [cured individuals] current infection with liv-
ing cysticerci). 3, 7 
 MATERIALS AND METHODS 
 The sampling protocol of the present study has been 
described elsewhere. 4 Briefly, a community-based study was 
conducted between September and November 2007 in the 
parish of Cazaderos, situated in the southern Andean prov-
ince of Loja, where CC is endemic. 8 
 A total of 791 human serum samples were collected and 
tested using three serological methods, namely the enzyme-
linked immunosorbent assay (Ag-ELISA) for the detection 
of circulating antigens of the metacestode of  T. solium , 9 the 
enzyme-linked immunoelectrotransfer blot assay (EITB) for 
the detection of antibodies directed against seven specific 
T. solium glycoprotein antigens, 10 and the ELISA for the detec-
tion of antibodies directed against crude cyst-fluid extracts 
(Ab-ELISA). 11 The results of the three tests applied on 791 
individuals are shown in  Table 1 . 
 Bayesian analysis.  Because none of the serological tests 
included in this study is a gold standard, a Bayesian analysis 
was used to estimate the prevalence and characteristics of the 
tests. Two definitions of a case have been considered to make 
a distinction between prevalence of infection (an individual 
who is currently infected by living cysts 7 ) and prevalence of 
recent exposure to the parasite (an individual who has been 
in contact with the parasite during the precedent year, with 
or without development of cysticerci and with or without 
[cured individuals] current infection with living cysticerci 3, 7 ). 
A multinomial Bayesian model adapted from Berkvens and 
others 6 was used (Supplemental Appendix S1, available at 
 www.ajtmh.org ). Prior information on the test characteristics 
was extracted from the available literature according to the 
two above-mentioned definitions of a case and adapted by 
experts of the Institute of Tropical Medicine of Antwerp 
(Belgium) to be expressed as conditional probabilities ( Tables 2 
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and  3 ). 9– 12 The models allow for estimation of the credibility 
intervals for differences between the prevalence estimates of 
infection and exposure, between the characteristics of the same 
test estimated for each prevalence definition, and between the 
characteristics of the tests (2 × 2) for the detection of infected 
and exposed individuals. A credibility interval with both limits 
having the same sign (zero not included in the interval) can 
be interpreted as the equivalent of a significant result in a 
frequentist approach. 
 The analysis was conducted in WinBUGS and R. 13, 14 Criteria 
assessing the fit between prior information and test results were 
evaluated (i.e., the Bayesian  P value [Bayesp], the Deviance 
Information Criterion [DIC], and the number of parameters 
effectively estimated by the model [pD]). 6, 13 
 Ethical clearance.  The protocol of this study was approved 
by the Ethical Committee of the Central University of Ecuador 
and the Ethical Committee of the University Teaching Hospital 
of Antwerp, Belgium. Informed consent was obtained from 
all adult participants and the parents or legal guardians of 
minors. 
 RESULTS 
 The estimates of the prevalence of infection/exposure 
and the characteristics of the three serological tests for 
the detection of infected/exposed individuals are shown in 
Table 4 . The prevalence of infection by living cysts was 
estimated at 1% (95% confidence interval [CI] = 0–3%), 
whereas the prevalence of exposure to  T. solium within the 
precedent year was 23% (95% CI = 19–27%). 
 A statistical difference was detected between the preva-
lence of infection and exposure and between the sensitivity of 
the Ag-ELISA, the sensitivity of the Ab-ELISA, and the spec-
ificity of the EITB, depending on the case definition. 
 A statistical difference was detected between the specific-
ities of Ag-ELISA and EITB, the specificities of Ag-ELISA 
and Ab-ELISA, and the specificities of EITB and Ag-ELISA 
for the detection of infected individuals. A statistical differ-
ence was detected between the sensitivities of Ag-ELISA and 
EITB, the sensitivities of Ag-ELISA and Ab-ELISA, the sensi-
tivities of EITB and Ab-ELISA, the specificities of Ag-ELISA 
and Ab-ELISA, and the specificities of EITB and Ab-ELISA 
for the detection of exposed individuals. 
 Table 1 
 Results of the three serological tests applied on 791 individuals of 
Cazaderos 
Ag-ELISA EITB Ab-ELISA Number
1 1 1 11
1 1 0 2
1 0 1 5
1 0 0 5
0 1 1 90
0 1 0 96
0 0 1 206
0 0 0 376
 0 = negative test result; 1 = positive test result; Ag-ELISA = enzyme-linked immunosor-
bent assay for the detection of circulating antigens of the metacestode of  T. solium ; EITB = 
enzyme-linked immunoelectrotransfer blot assay for the detection of antibodies directed 
against seven specific  T. solium glycoprotein antigens; Ab-ELISA = enzyme-linked immu-
nosorbent assay for the detection of antibodies directed against crude cyst-fluid extracts of 
T. solium ; number = number of individuals for each result category. 
 Table 2 
 Prior information for the detection of infected individuals (uniform 
distributions ) * 
Conditional probabilities
Prior 
information
Sensitivity of the Ag-ELISA for the detection of infected 
individuals (th1[2] in the model in Supplemental 
Appendix S1) 0.8–1
Specificity of the Ag-ELISA for the detection of infected 
individuals (th1[3] in the model in Supplemental 
Appendix S1) 0.9–1
Probability to have a positive result for the EITB if the 
individual is infected and positive for the Ag-ELISA 
(th1[4] in the model in Supplemental Appendix S1) 0.95–1
Probability to have a positive result for the Ab-ELISA 
if the individual is infected and positive for the 
Ag-ELISA and the EITB (th1[8] in the model in 
Supplemental Appendix S1) 0.9–1
 * The other probabilities are not constrained and left as uniform distributions (0–1). 
 Ag-ELISA = enzyme-linked immunosorbent assay for the detection of circulating antigens 
of the metacestode of  T. solium ; EITB = enzyme-linked immunoelectrotransfer blot assay for 
the detection of antibodies directed against seven specific  T. solium glycoprotein antigens; 
Ab-ELISA = enzyme-linked immunosorbent assay for the detection of antibodies directed 
against crude cyst-fluid extracts of  T. solium . 
 Table 3 
 Prior information for the detection of exposed individuals (uniform 
distributions) * 
Conditional probabilities
Prior 
information
Specificity of the Ag-ELISA for the detection of exposed 
individuals (th2[3] in the model in Supplemental 
Appendix S1) 0.9–1
Probability to have a positive result for the EITB if the 
individual is exposed and positive for the Ag-ELISA 
(th2[4] in the model in Supplemental Appendix S1) 0.95–1
Probability to have a positive result for the EITB if the 
individual is exposed and negative for the Ag-ELISA 
(th2[5] in the model in Supplemental Appendix S1) 0.95–1
Probability to have a negative result for the EITB if the 
individual is not exposed and negative for the Ag-ELISA 
(th2[6] in the model in Supplemental Appendix S1) 0.95–1
Probability to have a positive result for the Ab-ELISA 
if the individual is exposed and positive for the 
Ag-ELISA and the EITB (th2[8] in the model in 
Supplemental Appendix S1) 0.9–1
Probability to have a negative result for the Ab-ELISA 
if the individual is exposed and negative for the 
Ag-ELISA and the EITB (th2[12] in the model in 
Supplemental Appendix S1) 0.5–1
 * The other probabilities are not constrained and left as uniform distributions (0–1). 
 Ag-ELISA = enzyme-linked immunosorbent assay for the detection of circulating antigens 
of the metacestode of  T. solium ; EITB = enzyme-linked immunoelectrotransfer blot assay for 
the detection of antibodies directed against seven specific  T. solium glycoprotein antigens; 
Ab-ELISA = enzyme-linked immunosorbent assay for the detection of antibodies directed 
against crude cyst-fluid extracts of  T. solium . 
 Table 4 
 Estimates of the prevalence of infection/exposure to the parasite and 
the characteristics of the three serological tests for the detection of 
infected/exposed individuals 
 CI = credibility interval; Se = sensitivity; Sp = specificity; Ag-ELISA = enzyme-linked 
immunosorbent assay for the detection of circulating antigens of the metacestode of 
 T. solium ; EITB = enzyme-linked immunoelectrotransfer blot assay for the detection of anti-
bodies directed against seven specific  T. solium glycoprotein antigens; Ab-ELISA = enzyme-
linked immunosorbent assay for the detection of antibodies directed against crude cyst-fluid 
extracts of  T. solium . 
Prevalence
Ag-ELISA EITB Ab-ELISA
Se Sp Se Sp Se Sp
Infection 0.01 0.90 0.98 0.93 0.76 0.89 0.61
CI lower 95% limit 0.00 0.80 0.97 0.82 0.72 0.79 0.58
CI upper 95% limit 0.03 0.99 0.99 0.99 0.79 0.97 0.65
Exposure 0.23 0.05 0.98 0.97 0.97 0.51 0.64
CI lower 95% limit 0.19 0.01 0.96 0.95 0.94 0.41 0.60
CI upper 95% limit 0.27 0.10 0.99 1.00 0.99 0.60 0.68
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 DISCUSSION 
 This study gives an estimation of the prevalence of infection 
and exposure and the characteristics of three diagnostic tests 
to detect individuals infected with  T. solium cysts and individu-
als exposed to the parasite inside an entire population living 
in an endemic area. The estimated prevalence of infection was 
statistically lower than the estimated prevalence of exposure to 
the parasite. As expected, antibody detection by EITB showed 
a high sensitivity and specificity to detect exposed individuals. 
One could expect identical results for the Ab-ELISA because 
it also detects antibodies, but both sensitivity and specificity 
of this test were statistically lower than the same estimates for 
the EITB. The use of crude cyst-fluid extracts could explain 
the lack of specificity of this test to detect exposure, because 
cross-reactions with many other parasites are suspected. 15 
However, the low sensitivity of the technique could be caused 
by the complex conformation of the crude antigens, which stay 
inaccessible for antibodies in contrast to the EITB-purified 
glycoproteins. The three tests had a relatively high sensitiv-
ity to detect infection, but the specificity of both EITB and 
Ab-ELISA were statistically lower than the specificity of the 
Ag-ELISA. This can be explained by the high number of false 
positives for these two tests detecting antibodies, because they 
were not able to discriminate between exposure and infection. 
Indeed, antibodies can be present in currently infected individ-
uals but also in individuals who were infected and cured and 
individuals who were exposed to the parasite without devel-
oping the disease. 3 Additionally, the Ag-ELISA was insensi-
tive to detect exposure to the parasite, because it only detects 
individuals infected with living cysts excreting antigens. 7 
 In conclusion, this study shows the importance of the defini-
tion of a case (infection or exposure) when attempting to esti-
mate the prevalence of a disease and the characteristics of the 
diagnostic tests. It underlines the necessity of using a multiple-
testing approach when no gold standard is available but high-
lights the need of interpreting expert opinion and published 
information carefully to use it properly in a Bayesian analysis, 
particularly when this information is based on clinical studies. 
Moreover, these findings point out the low performances of 
the Ab-ELISA using crude cyst-fluid extracts and cast doubt 
on the suitability of the use of crude antigens for diagnosing 
CC. Prior information on the test characteristics was based 
on the available literature according to the two definitions of 
a case and expert opinion. However, ongoing cohort studies 
on NCC using imaging as a gold-standard technique suggest 
a variation in the performances of the serological methods 
as a function of the level of infection (unpublished results). 
When available, different prior information scenarios should 
be included in the present Bayesian statistical model, and the 
results should be compared. 
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